Revenue of Cartilage Degeneration Market Is Estimated To Generate US$ 16 Billion by 2027

The global cartilage degeneration market is valued at US$ 12.1 billion in 2022 and is estimated to generate US$ 16 billion in revenue by the end of 2027, and expanding at a CAGR of 5.7% over the next five years.

An increasing number of joint replacement surgeries across the world is expected to drive demand for joint replacements at a CAGR of 6%, which is the highest among all procedures.

In the years to come, it is also expected that an increase in the number of accidents and injuries will fuel demand for cartilage repair. Other factors that affect the potential of the cartilage degeneration market include the growing elderly population, rising obesity rates, an increase in sports injuries, and technological advancements in the global cartilage repair market.

Download Free Sample Copy of This Report:

https://www.factmr.com/connectus/sample?flag=S&rep_id=7738

Competitive Landscape

Top companies in the cartilage degeneration industry are focusing on creating novel cartilage repair and restoration products to increase their business potential.

• Cytonics, a biotechnology research and development company specializing in therapeutics for osteoarthritis is focusing on creating a blood protein that blocks destructive enzymes that cause degeneration of cartilage tissue. The CYT-108 is an advanced genetically engineered variant of Alpha -2-macroglobulin, a blood protein that helps in cartilage repair by blocking out destructive enzymes.

Companies in the cartilage degeneration market are also focusing on obtaining new approvals for their products to enhance their market presence and drive revenue generation capacity.

• In March 2022, CartiHeal Ltd., an Israel-based developer of implants for the treatment of cartilage defects announced that its Agili-C™ implant was granted Premarket Approval (PMA) by the U.S. FDA (Food and Drug Administration). The approval was based on the results of a two-year IDE clinical study.

Share Your Requirements & Get Customized Reports :

https://www.factmr.com/connectus/sample?flag=RC&rep_id=7738

Key Companies Profiled by Fact.MR

• DePuy Synthes
• Zimmer Biomet
• Stryker Corporation
• Smith & Nephew plc
• B. Braun Melsungen AG
• Medtronic plc.
• Johnson & Johnson (DePuy Synthes)
• Osiris Therapeutics Inc.
• Vericel Corporation
• Anika Therapeutics Inc.
• MEDIPOST Co. Ltd.
• CONMED Corporation
• Arthrex Inc.

Key Segments in Cartilage Degeneration Industry Research

• By Procedure :

o Joint Replacements
o Chondroplasty
o Osteochondral Transplants
o Microfracture
o Meniscus Transplants
o Cell-based Cartilage Resurfacing
o Autologous Chondrocyte Implantation
o Others

• By Application :

o Knees
o Hips
o Others

• By Treatment Delivery Channel :

o Hospitals
o Academic & Research Institutes
o Specialty Clinics
o Ambulatory Surgical Centers
o Others

• By Region :

o North America
o Latin America
o Europe
o APAC
o MEA

Get Full Access to this Report :

https://www.factmr.com/checkout/7738

Questionnaire answered in the Cartilage
Degeneration Market report include:

• How the market for Cartilage Degeneration has grown?
• What is the present and future outlook of the global Cartilage Degeneration on the basis of region?
• What are the challenges and opportunities for the Cartilage Degeneration?
• Why the consumption of Cartilage Degeneration highest in region?
• In which year segment is expected to overtake segment?

Table of Content

1. Global Cartilage Degeneration Market - Executive Summary

1.1. Global Market Overview
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Fact.MR Analysis and Recommendations

2. Global Cartilage Degeneration Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Introduction and Definition

3. Market Risks and Trends Assessment

3.1. Risk Assessment
3.2. Key Trends Impacting the Market
3.3. Formulation and Source Development Trends

4. Market Background and foundation Data Points

4.1. Need of the Hour for Industries
4.2. Industry Wise Industry 4.0
4.3. Cartilage Degeneration - Strategic Priorities
4.4. Life Cycle Stage
4.5. Importance of Technology

Contd…

Explore Fact.MR's More Insights on the Healthcare Domain

Skincare Device Market: https://www.prnewswire.com/news-releases/sales-of-skincare-devices-to-surpass-uss-43-48-bn-as-prevalence-of-dermatological-diseases-increases-factmr-report-301506974.html

ENT Medical Devices Market: https://www.prnewswire.com/news-releases/ear-nose-throat-ent-medical-devices-manufacturers-target-applications-in-cataract--glaucoma-treatment-factmr-301262063.html

21st floor , 136 Sejong-daero,
Seoul,100-768
South Korea
Phone: +1 (628) 251-1583
Email: sales@factmr.com

Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed . Our sales offices in United States and Dublin, Ireland. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.